NOVEL THERAPEUTIC STRATEGIES FOR TYPE 2 DIABETES

被引：0
|
作者：
Gallwitz, B. [1 ]
机构：
[1] Univ Tubingen, Dept Med 4, Tubingen, Germany
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2009年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：10 / 11
页数：2
相关论文
共 50 条
  • [21] INJECTABLE THERAPY IN TYPE 2 DIABETES MELLITUS: STRATEGIES TO IMPROVE THERAPEUTIC ADHERENCE
    Gurova, Olga Y.
    Fadeev, Valentin V.
    Maloletkina, Ekaterina S.
    DIABETES MELLITUS, 2018, 21 (06): : 524 - 533
  • [22] Type 2 diabetes mellitus-Its global prevalence and therapeutic strategies
    Jain, Shelesh
    Saraf, Swarnlata
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2010, 4 (01) : 48 - 56
  • [23] Myocardial Calcium Handling in Type 2 Diabetes: A Novel Therapeutic Target
    Dattani, Abhishek
    Singh, Anvesha
    Mccann, Gerry P.
    Gulsin, Gaurav S.
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2024, 11 (01)
  • [24] Targeting metabolic pathways: a novel therapeutic direction for type 2 diabetes
    Song, Zhihui
    Yan, An
    Guo, Zehui
    Zhang, Yuhang
    Wen, Tao
    Li, Zhenzhen
    Yang, Zhihua
    Chen, Rui
    Wang, Yi
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [25] GPR30 Novel Therapeutic Target for Type 2 Diabetes
    Kumar, Rajesh
    Balhusizen, Alexander
    Salehi, Albert
    DIABETES, 2010, 59 : A444 - A444
  • [26] Mechanism of action of Imeglimin: A novel therapeutic agent for type 2 diabetes
    Hallakou-Bozec, Sophie
    Vial, Guillaume
    Kergoat, Micheline
    Fouqueray, Pascale
    Bolze, Sebastien
    Borel, Anne-Laure
    Fontaine, Eric
    Moller, David E.
    DIABETES OBESITY & METABOLISM, 2021, 23 (03): : 664 - 673
  • [27] ASPROSIN AND TYPE 2 DIABETES MELLITUS: A NOVEL POTENTIAL THERAPEUTIC IMPLICATION
    Bhadel, P.
    Shrestha, S.
    Sapkota, B.
    Li, J-Y.
    Tao, H.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (01): : 1 - 7
  • [28] New therapeutic strategies for type 1 diabetes mellitus
    Barajas, M.
    Principe, R. M.
    Escalada, J.
    Prosper, F.
    Salvador, J.
    ANALES DEL SISTEMA SANITARIO DE NAVARRA, 2008, 31 (03) : 219 - 234
  • [29] AN UPDATE ON EXENATIDE, A NOVEL THERAPEUTIC OPTION FOR PATIENTS WITH TYPE 2 DIABETES
    Crasto, W.
    Khunti, K.
    Davies, M. J.
    DRUGS OF TODAY, 2011, 47 (11) : 839 - 856
  • [30] Novel therapeutic approach to target endothelial dysfunction in type 2 diabetes
    Sena, C. M.
    Pereira, A. M.
    Fernandes, R.
    Santos-Silva, D.
    Faustino, A.
    Ceica, R.
    CARDIOVASCULAR RESEARCH, 2014, 103
12345